| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |